PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial

Fahong Li(Fudan University), Jiming Zhang(Huashan Hospital), Lihong Qu(Shanghai East Hospital), Yifei Guo(Fudan University), Qiran Zhang(Fudan University), Richeng Mao(Fudan University), Zhongliang Shen(Fudan University), Qingxing Li(Wenzhou Medical University), Xinxin Zhang(Ruijin Hospital), Jinyu Wang(Fudan University), Yongmei Zhang(Xuzhou Medical College), Wenhong Zhang(Huashan Hospital), Xiaoping Wu(Nanchang University), Haoxiang Zhu(Fudan University), Yuxian Huang(Huashan Hospital), Xun Qi(Shanghai Public Health Clinical Center), Jie Yu(Chinese Academy of Sciences), Feifei Yang(Fudan University), Yanhong Liu(Shanghai Jiao Tong University), Liang Chen(Smithsonian Institution), Fengdi Zhang(Shanghai East Hospital)
Journal of Hepatology
July 31, 2024
Cited by 18


Related Papers